FR2851471B1 - Composes comprenant au moins une substance active et au moins un vecteur relies par un agent de liaison, leurs utilisations et lesdits agents de liaison - Google Patents

Composes comprenant au moins une substance active et au moins un vecteur relies par un agent de liaison, leurs utilisations et lesdits agents de liaison

Info

Publication number
FR2851471B1
FR2851471B1 FR0302242A FR0302242A FR2851471B1 FR 2851471 B1 FR2851471 B1 FR 2851471B1 FR 0302242 A FR0302242 A FR 0302242A FR 0302242 A FR0302242 A FR 0302242A FR 2851471 B1 FR2851471 B1 FR 2851471B1
Authority
FR
France
Prior art keywords
compounds
active substance
binding
binding agent
vector connected
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0302242A
Other languages
English (en)
Other versions
FR2851471A1 (fr
Inventor
Anthony R Rees
Patrick Mouchet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Synt EM SA
Original Assignee
Synt EM SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synt EM SA filed Critical Synt EM SA
Priority to FR0302242A priority Critical patent/FR2851471B1/fr
Priority to PCT/FR2004/000413 priority patent/WO2004075922A2/fr
Publication of FR2851471A1 publication Critical patent/FR2851471A1/fr
Application granted granted Critical
Publication of FR2851471B1 publication Critical patent/FR2851471B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/65—Peptidic linkers, binders or spacers, e.g. peptidic enzyme-labile linkers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR0302242A 2003-02-24 2003-02-24 Composes comprenant au moins une substance active et au moins un vecteur relies par un agent de liaison, leurs utilisations et lesdits agents de liaison Expired - Fee Related FR2851471B1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR0302242A FR2851471B1 (fr) 2003-02-24 2003-02-24 Composes comprenant au moins une substance active et au moins un vecteur relies par un agent de liaison, leurs utilisations et lesdits agents de liaison
PCT/FR2004/000413 WO2004075922A2 (fr) 2003-02-24 2004-02-24 Composes comprenant au moins une substance active et au moins un vecteur relies par un agent de liaison, leurs utilisation et lesdits agents de liaison

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0302242A FR2851471B1 (fr) 2003-02-24 2003-02-24 Composes comprenant au moins une substance active et au moins un vecteur relies par un agent de liaison, leurs utilisations et lesdits agents de liaison

Publications (2)

Publication Number Publication Date
FR2851471A1 FR2851471A1 (fr) 2004-08-27
FR2851471B1 true FR2851471B1 (fr) 2006-07-28

Family

ID=32799540

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0302242A Expired - Fee Related FR2851471B1 (fr) 2003-02-24 2003-02-24 Composes comprenant au moins une substance active et au moins un vecteur relies par un agent de liaison, leurs utilisations et lesdits agents de liaison

Country Status (2)

Country Link
FR (1) FR2851471B1 (fr)
WO (1) WO2004075922A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7696166B2 (en) 2006-03-28 2010-04-13 Albany Molecular Research, Inc. Use of cyclosporin alkyne/alkene analogues for preventing or treating viral-induced disorders
US7696165B2 (en) 2006-03-28 2010-04-13 Albany Molecular Research, Inc. Use of cyclosporin alkyne analogues for preventing or treating viral-induced disorders

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0037388B1 (fr) * 1980-03-31 1984-12-12 Institut International De Pathologie Cellulaire Et Moleculaire Formes pharmaceutiques, leur préparation et les compositions qui les contiennent
JPS63502716A (ja) * 1986-03-07 1988-10-13 マサチューセッツ・インステチュート・オブ・テクノロジー 糖タンパク安定性の強化方法
US5164372A (en) * 1989-04-28 1992-11-17 Fujisawa Pharmaceutical Company, Ltd. Peptide compounds having substance p antagonism, processes for preparation thereof and pharmaceutical composition comprising the same
JP2001206897A (ja) * 2000-01-26 2001-07-31 Nippon Seibutsu Seizai:Kk ハイドロキシプロリン誘導体
SK12872002A3 (sk) * 2000-03-15 2003-05-02 Bristol-Myers Squibb Pharma Company Cielené antineoplastické lieky a ich terapeutické použitie
AU2002212107A1 (en) * 2000-11-02 2002-05-15 Maxygen Aps New multimeric interferon beta polypeptides
FR2836474B1 (fr) * 2002-02-22 2004-12-24 Synt Em Composes, compositions et methode pour le transport des molecules de cyclosporine a travers la barriere hemato-encephalique

Also Published As

Publication number Publication date
WO2004075922A3 (fr) 2005-01-20
WO2004075922A2 (fr) 2004-09-10
FR2851471A1 (fr) 2004-08-27

Similar Documents

Publication Publication Date Title
BR0209242A (pt) Aminopolidiorganossiloxanos amido-funcionais
BR0014997B1 (pt) concentrado anticongelante, e, composição refrigerante aquosa.
DK1792927T3 (da) Ny blokcopolymer, micelletilberedning og anticancermiddel indeholdende samme som aktiv ingrediens
DE60134937D1 (de) Zweifüssiger, laufender Roboter
IL166730A0 (en) N-(3-methoxy-5-methylpyrazin-2-yl)-2-(4-Ä1,3,4-oxadiazol-2-ylÜphenyl)pyridine-3-sulphonamide as an anticancer agent
BR0008100B1 (pt) estabilizador de modo lateral para um fluxìmetro coriolis.
DE60138903D1 (de) N-(1,2,4-triazoloazinyl)thiophensulfonamid-verbindungen als herbizide
ITTO20000331A0 (it) Composizioni pesticide.
DK1077976T3 (da) Vandopløselige azoler som bredspektrede antisvampemidler
ITRM20000703A0 (it) Dispositivo ammortizzatore di torsione, in particolare per innesto.
FR2851471B1 (fr) Composes comprenant au moins une substance active et au moins un vecteur relies par un agent de liaison, leurs utilisations et lesdits agents de liaison
ITTO20000385A0 (it) Composizione pesticida.
ITTO20000371A0 (it) Composizioni pesticide.
ITTO20000386A0 (it) Composizione pesticida.
FR2811911B1 (fr) Dispersions comprenant au moins un agent emulsifiant choisi parmi les polysaccharides, le polysaccharide etant un heteroxylane
ATE252086T1 (de) 4-oxo-1,4-dihydro-3-cinnolinecarbonsäure-amide als antivirusmittel
FR2876910B1 (fr) Complexe comprenant la mequitazine, une cyclodextrine et un agent d'interaction
邹宇泽 et al. Increased Three Times, or Increased Two Times
Pettis Avian Flu
丁一 SGML & HTML
RU2000116332A (ru) Антгельминтное средство
FR2810300B1 (fr) Conditionnement en un materiau semi-rigide, comprenant deux parties emboitables
杨婕 HELLO! SUMMER
AR027974A1 (es) 1-aril-ciclopropilmetilamino-1,3,5-triazinas substituidas
Singh et al. 10 pratinidhi kahāniyām̐

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20071030